Such immunotoxins, targeting mesothelin on pancreatic cancer cells or the transferrin receptor on small cell lung cancer cells, were successfully combined with ABT-263/737 and induced death in cells that were shown to be resistant against the individual components (Mattoo and FitzGerald, 2013; Hollevoet et al., 2014). Here, TFRC is linked to pancreatic neoplasm.